Berlin/Frankfurt—Global law firm Dentons has advised numerous banks in their capacity as promissory note creditors of Biotronik Group on obtaining repayment of their note loans.
The full repayment was completed on July 30, 2025, following the successful refinancing of Biotronik.
A Dentons team led by Andreas Ziegenhagen has been providing comprehensive advice to Biotronik Group’s promissory note creditors since 2023 with regard to the refinancing and related agreements. The team advised the group of creditors and provided intensive support throughout the restructuring period as promissory note representative.
Biotronik is a leading global medical technology company based in Berlin and a pioneer in cardiovascular, endovascular, and neuromodulatory solutions. The company develops and sells products and services that aim to improve the lives of people with cardiovascular disease and chronic pain. Biotronik is represented in over 100 countries in the Americas, EMEA, and Asia-Pacific regions.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
